Finance

Lists
TTOO:OTCMKTS
T2 Biosystems Inc
0,00060 US$
0,00%
(0,00) 1D
1 ოქტ, 12:58:43 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TTOO...
Mkt. cap
16,83 ათ.
Avg. vol.
7,17 ათ.
Volume
95,00
52-wk high
0,08 US$
52-wk low
0,00 US$
Beta
0,87
Shares outstanding
28,04 მლნ.
No. of employees
113
Mkt. cap
16,83 ათ.
Avg. vol.
7,17 ათ.
Volume
95,00
52-wk high
0,08 US$
52-wk low
0,00 US$
Beta
0,87
Shares outstanding
28,04 მლნ.
No. of employees
113
News stories
From web sources and news partners
About T2 Biosystems Inc
CEO-
Employees113
Founded2006
HeadquartersLexington, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websiteinvestors.t2biosystems.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2023
მარ. 2024
ივნ. 2024
სექ. 2024
Revenue
-
2,06 მლნ.
1,95 მლნ.
1,98 მლნ.
Cost of goods sold
-
-
-
6,75 მლნ.
Cost of revenue
-
-
-
6,75 მლნ.
Research and development expenses
-
-
-
22,00 ათ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,38 მლნ.
Operating expense
-
-
-
5,40 მლნ.
Total operating expenses
-
-
-
12,15 მლნ.
Operating income
-
-
-
-10,16 მლნ.
Other non operating income
-
-
-
414,00 ათ.
EBT including unusual items
-
-
-
-10,12 მლნ.
EBT excluding unusual items
-
-
-
-10,12 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-10,12 მლნ.
Net profit margin
-
-
-
-509,67%
Earnings per share
-
-2,66
-0,66
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-370,00 ათ.
Net interest expenses
-
-
-
-370,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-10,10 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები